Sarepta Therapeutics Shares “Quality of Life” Survey

December 2, 2021

Quality of Life Measures survey

Today, Sarepta shared their “Quality of Life Measures” survey for those who are living with Duchenne (age 16+) or caregivers of individuals living with Duchenne. The survey is meant to examine the effectiveness of quality-of-life measures for people with Duchenne muscular dystrophy and highlight any challenges. The survey will remain annonymous.

To start the survey, click here.

For further information regarding this study please contact the project lead:

  • George Morgan george.morgan@hcdeconomics.com
  • Dr Philip Powell – p.a.powell@sheffield.ac.uk

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open